Christine Fu

836 total citations
29 papers, 648 citations indexed

About

Christine Fu is a scholar working on Oncology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Christine Fu has authored 29 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Christine Fu's work include CAR-T cell therapy research (14 papers), Glaucoma and retinal disorders (5 papers) and Axon Guidance and Neuronal Signaling (4 papers). Christine Fu is often cited by papers focused on CAR-T cell therapy research (14 papers), Glaucoma and retinal disorders (5 papers) and Axon Guidance and Neuronal Signaling (4 papers). Christine Fu collaborates with scholars based in United States, Canada and Türkiye. Christine Fu's co-authors include David W. Sretavan, John F. Bechberger, Mark A. Ozog, Christian C. Naus, Bernard Perbal, Tony Tran, Jiulin Du, Doo Hun Lim, Janet Koprivnikar and Kathrin Klein and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Christine Fu

28 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Fu United States 12 306 122 120 111 65 29 648
Abigail H. Conrad United States 15 351 1.1× 88 0.7× 44 0.4× 54 0.5× 16 0.2× 32 753
Terry Morris United States 14 343 1.1× 19 0.2× 138 1.1× 72 0.6× 13 0.2× 16 754
Judith D. Ochrietor United States 13 430 1.4× 52 0.4× 112 0.9× 52 0.5× 43 0.7× 23 609
Merideth C. Kamradt United States 7 746 2.4× 73 0.6× 38 0.3× 73 0.7× 13 0.2× 11 898
Natasha Levenkova United States 11 532 1.7× 24 0.2× 46 0.4× 51 0.5× 36 0.6× 13 902
Xiaoyin Ma China 16 382 1.2× 128 1.0× 22 0.2× 13 0.1× 48 0.7× 32 581
Sílvia Albert United States 16 614 2.0× 143 1.2× 89 0.7× 35 0.3× 13 0.2× 58 889
P. Jaya Kausalya Singapore 14 680 2.2× 10 0.1× 35 0.3× 101 0.9× 17 0.3× 18 1.1k
Kenneth A. Wilson United States 11 140 0.5× 31 0.3× 56 0.5× 31 0.3× 24 0.4× 23 430
Yihua Zhu China 14 500 1.6× 107 0.9× 45 0.4× 49 0.4× 3 0.0× 44 726

Countries citing papers authored by Christine Fu

Since Specialization
Citations

This map shows the geographic impact of Christine Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Fu more than expected).

Fields of papers citing papers by Christine Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Fu. The network helps show where Christine Fu may publish in the future.

Co-authorship network of co-authors of Christine Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Fu. A scholar is included among the top collaborators of Christine Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Fu. Christine Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viswanathan, Meera, Jennifer S Lin, Rania Ali, et al.. (2025). Perspectives on Racial and Ethnic Health Equity in Systematic Reviews and Evidence-Based Guidelines. Annals of Internal Medicine. 178(11_Supplement). e2403875–e2403875. 3 indexed citations
2.
Ahmed, Nausheen, Fang Sun, Christie Teigland, et al.. (2024). Chimeric Antigen Receptor T-Cell Access in Patients with Relapsed/Refractory Large B-Cell Lymphoma: Association of Access with Social Determinants of Health and Travel Time to Treatment Centers. Transplantation and Cellular Therapy. 30(7). 714–725. 9 indexed citations
3.
Wu, James J., et al.. (2024). Medicare Utilization and Cost Trends for CAR T Cell Therapies Across Settings of Care in the Treatment of Diffuse Large B-Cell Lymphoma. Advances in Therapy. 41(8). 3232–3246. 1 indexed citations
4.
Wang, Zhaojun, Yan Li, Christine Fu, et al.. (2024). Semaglutide promotes the transition of microglia from M1 to M2 type to reduce brain inflammation in APP/PS1/tau mice. Neuroscience. 563. 222–234. 8 indexed citations
5.
Tsang, Jonathan, et al.. (2024). Axicabtagene Ciloleucel Manufacturing Experience from Launch to Present Day: A United States Perspective. Transplantation and Cellular Therapy. 30(2). S203–S204.
6.
Wu, James J., Armin Ghobadi, Richard T. Maziarz, et al.. (2024). Medicare Utilization and Cost Trends for CAR-T Cell Therapies in the Treatment of Large B-Cell Lymphoma. Transplantation and Cellular Therapy. 30(2). S406–S407. 1 indexed citations
9.
Jacobson, Caron A., Michael Hemmer, Zhen‐Huan Hu, et al.. (2023). S223: REAL-WORLD EARLY OUTCOMES OF AXICABTAGENE CILOLEUCEL FOR RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA. HemaSphere. 7(S3). e31464ce–e31464ce. 1 indexed citations
11.
Locke, Frederick L., Zhen‐Huan Hu, Tanya Siddiqi, et al.. (2022). Real-World Impact of Time from Leukapheresis to Infusion (Vein-to-Vein Time) in Patients with Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Treated with Axicabtagene Ciloleucel. Blood. 140(Supplement 1). 7512–7515. 13 indexed citations
13.
Fu, Christine & David W. Sretavan. (2012). Ectopic Vesicular Glutamate Release at the Optic Nerve Head and Axon Loss in Mouse Experimental Glaucoma. Journal of Neuroscience. 32(45). 15859–15876. 26 indexed citations
14.
Fu, Christine & David W. Sretavan. (2011). Involvement of EphB/Ephrin-B Signaling in Axonal Survival in Mouse Experimental Glaucoma. Investigative Ophthalmology & Visual Science. 53(1). 76–76. 18 indexed citations
15.
Koprivnikar, Janet, et al.. (2010). Effects of temperature, salinity, and pH on the survival and activity of marine cercariae. Parasitology Research. 106(5). 1167–1177. 65 indexed citations
16.
Fu, Christine, et al.. (2007). Regions in the 3′ untranslated region confer stage-specific expression to the Leishmania mexicana a600-4 gene☆. Molecular and Biochemical Parasitology. 153(2). 125–132. 11 indexed citations
17.
Du, Jiulin, Christine Fu, & David W. Sretavan. (2007). Eph/ephrin Signaling as a Potential Therapeutic Target After Central Nervous System Injury. Current Pharmaceutical Design. 13(24). 2507–2518. 54 indexed citations
18.
Tran, Tony, et al.. (2007). Upregulation ofEphB2andephrin-B2at the Optic Nerve Head of DBA/2J Glaucomatous Mice Coincides with Axon Loss. Investigative Ophthalmology & Visual Science. 48(12). 5567–5567. 28 indexed citations
19.
Haberl, Michael, Kathrin Klein, Christine Fu, et al.. (2005). Three haplotypes associated with CYP2A6 phenotypes in Caucasians. Pharmacogenetics and Genomics. 15(9). 609–624. 79 indexed citations
20.
Fu, Christine, John F. Bechberger, Mark A. Ozog, Bernard Perbal, & Christian C. Naus. (2004). CCN3 (NOV) Interacts with Connexin43 in C6 Glioma Cells. Journal of Biological Chemistry. 279(35). 36943–36950. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026